Back to search

Programs & Services


Southern Alberta Respiratory Syncytial Virus (RSV) Prevention Program

Provides RSV immunoprophylaxis( palivizumab) to children under 2 years of age considered high risk for severe RSV disease residing in southern Alberta.

Submission of the Risk Assessment form by a health care professional is required to determine a child's eligibility for palivizumab. Risk Assessment forms available on the RSV Prevention Risk Prevention Program website.

Access
Service Providers May Include
doctors, pediatricians, registered nurses (RNs)
Eligibility

Children under the age of 2 with underlying medical conditions considered high risk for severe RSV disease.

Service Access

Healthcare providers should consult the Alberta Referral Directory for service referral information.


Service Locations
Also Known As
Acronym
SARPP